It was low in all nonrecurrent cases [Table/Fig-6]. mean postoperative follow-up period was 4 y (range 28 months5 y). Only six patients showed recurrence. In these cases, the site of GCTTS recurrence was the phalanx of the hand. The mean Ki-67 index in the recurrence cases was 6. 5%, whereas it was 2 . 3% in those without recurrence. Summary: The Ki-67 proliferation index and mitotic activity were increased in recurrent cases compared to nonrecurrent cases. Therefore , these parameters may be helpful in predicting recurrence of GCTTS. However , adequate surgical excision and complete removal of the Tumour are important steps to minimize the recurrence rate. Keywords: Giant cell tumour, Ki-67, Proliferation index, Recurrence, Tendon sheath == Intro == A giant cell tumour of the tendon sheath (GCTTS) originates from the synovial Rabbit Polyclonal to IKZF2 cells of the tendon sheath. It has a slow clinical course and is one of the most common soft tissue tumours of the hand. Although less common, it may also be observed in the ankle, elbow, knee, wrist, spine, and fingers. The pathological nature of this disease is controversial. Some authors consider that it has a neoplastic nature, whereas other believe it is a non-neoplastic tumour. The underlying etiology is believed to include trauma, inflammation, metabolic diseases, and neoplasia. The most widely accepted pathogenic hypothesis is reactive or regenerative hyperplasia associated with an inflammatory process. The treatment of GCTTS is surgical excision. There is a high rate of recurrence of the tumour after excision. Many factors are considered as causing recurrence, including incomplete excision of the lesion, proximity to the distal interphalangeal joints, presence of degenerative joint disease, radiological erosion and increased mitotic AH 6809 activity. To prevent recurrence is complete surgical excision with removal of all satellite nodules if present [13]. We aimed to investigate the relation between GCTTS recurrence and the Ki-67 proliferation index. At the same time, we reviewed the literature and performed a retrospective analysis of clinicopathological findings of GCTTS. == Materials and Methods == In this retrospective study, we evaluated 35 patients diagnosed with GCTTS in the Department of Pathology, School of Medicine, Recep Tayyip Erdogan University between 2009 and 2014. The parameters evaluated were age, gender, tumour location, treatment mode, and recurrence. Data from the clinic and pathology records were used. Sections 3-4 solid were obtained from the paraffin embedded blocks belonging to the selected suitable preparations fixed with formalin to study a monoclonal mouse antibody to human Ki-67 immunohistochemical method on positively charged AH 6809 slide. An immunohistochemical study was carried out using AH 6809 the streptavidin-biotin method and Ki-67 primary antibody (MM1, Cod: 801704, prediluted). Aminoethyl carbazole was used as a chromogen. Reverse staining was performed with Mayers hematoxylin, and the slides were cover slipped with mounting medium. The sections were examined under light microscopy. For Ki-67 staining, proliferative index (PI) was expressed as a percentage of positively stained cells out of 1000 tumour cells counted in the most mitotically active areas. Only the nuclei with a significant stain were deemed positive intended for staining. The mitotic rate was counted on 10 randomly selected microscopic areas (400). == Statistical Analysis == Statistical assessments have been performed by using SPSS software (SPSS version 16; SPSS Inc., Chicago, IL, USA). Continuous variables are expressed as meanSD and medium (minimum-maximum). In comparison of these 2 groups, Mann-Whitney U test and T student test was used. The.